Using smartphone ultrasound to improve trauma care in Cameroon
Smartphone ultrasonography to improve diagnosis and treatment of life-threatening injuries for trauma patients in Cameroon
This study is testing a new way to help doctors in Cameroon quickly diagnose and treat serious injuries using smartphones, so they can save more lives by training local healthcare providers to use this technology effectively.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10912029 on NIH RePORTER |
What this research studies
This research aims to enhance the diagnosis and treatment of life-threatening injuries in trauma patients in Cameroon by implementing a smartphone-based ultrasonography (SBU) program. The project will train local trauma providers to use this technology, which is currently underutilized due to limited access to traditional imaging methods. By evaluating the effectiveness of this training and the feasibility of SBU in the local context, the research seeks to improve timely diagnosis and treatment of injuries, ultimately reducing preventable deaths. The study will focus on both educational outcomes for providers and the impact on patient care.
Who could benefit from this research
Good fit: Ideal candidates for this research are trauma patients in Cameroon who require timely diagnosis and treatment for their injuries.
Not a fit: Patients who do not have access to trauma care facilities or those with non-trauma-related conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce preventable deaths from trauma in Cameroon by improving access to diagnostic imaging.
How similar studies have performed: Similar approaches using mobile technology for diagnostic imaging have shown promise in other low-resource settings, suggesting potential for success in this context.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Christie, Sabrinah Ariane — University of California Los Angeles
- Study coordinator: Christie, Sabrinah Ariane
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.